Skip to Main Content

Paper Details

Risk Estimation in Non-Enhancing Glioma: Introducing a Clinical Score.
0
2023
CDKN2A/B, Glioma, IDH, IDH mutation, NEG, NEGs, astrocytoma, glioblastoma, malignant glioma, non, non-enhancing glioma, patients
Author NameAffiliation
Andreas von DeimlingInstitute of Pathology, Heidelberg University Hospital
Andreas von DeimlingGerman Cancer Research Center (DKFZ)
Christel Herold-MendeHeidelberg University Hospital
Andreas UnterbergHeidelberg University Hospital
Christine JungkHeidelberg University Hospital
  • 1 - 5

Datasets

Release 1.2